PleuraSeal Pivotal Study (US)

NCT00748124 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
230
Enrollment
INDUSTRY
Sponsor class

Stopped Interim analysis results were not supportive of primary endpoint

Conditions

Interventions

Sponsor

Integra LifeSciences Corporation